<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05020171</url>
  </required_header>
  <id_info>
    <org_study_id>2021-00721</org_study_id>
    <secondary_id>14-O20</secondary_id>
    <nct_id>NCT05020171</nct_id>
  </id_info>
  <brief_title>Effects of a Lower Limb Strength Training Program on a Seated Robotic Device in Patients</brief_title>
  <acronym>Lambda_MIpil</acronym>
  <official_title>Effects of a Lower Limb Strength Training Program on a Seated Robotic Device in Subacute Stroke Patients: a Pilot Study.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Institution de Lavigny</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Institution de Lavigny</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The loss of lower limb strength that occurs after a stroke limits the patient's autonomy in&#xD;
      participating in activities of daily living, including gait performance. In the sub-acute&#xD;
      phase, it is difficult to implement a strengthening program, as weakness prevents exercise&#xD;
      being performed with the recommended parameters. This limit can be exceeded by using specific&#xD;
      robotic devices, which allow the effort provided to be adapted according to the patient's&#xD;
      capacities. In addition, motivation can be improved by the use of feedback or incentive&#xD;
      games. The aim of this pilot study is to obtain data on the effect of lower limb strength&#xD;
      training with a seated robotic device in subacute stroke patients for a future larger&#xD;
      randomised study. In addition, it aims to evaluate the recruitment rate, applicability,&#xD;
      resources for implementation and patient tolerance to the training program.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">August 20, 2021</start_date>
  <completion_date type="Anticipated">December 30, 2022</completion_date>
  <primary_completion_date type="Anticipated">October 31, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>change from study inclusion to end of intervention at 5 weeks in strength of knee extensor's</measure>
    <time_frame>Study inclusion to end of intervention at 5 weeks</time_frame>
    <description>measure with a manuel dynamometer, in newton</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>change from study inclusion to end of intervention at 5 weeks in Motricity index legs</measure>
    <time_frame>Study inclusion to end of intervention at 5 weeks</time_frame>
    <description>clinical manuel strength test, seating on a chair. From 0 to 33, 33 is normal strength.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>change from study inclusion to end of intervention at 5 weeks in timed up and go</measure>
    <time_frame>Study inclusion to end of intervention at 5 weeks</time_frame>
    <description>Mobility test: standing from a chair, walking 3 meters, turn around, returning and seat. in seconds</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>change from study inclusion to end of intervention at 5 weeks in 10 meters walk test</measure>
    <time_frame>Study inclusion to end of intervention at 5 weeks</time_frame>
    <description>measure of mean gait speed on 10 meters, at comfortable and maximum gait speed. In meters/second.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>change from study inclusion to end of intervention at 5 weeks in Ashworth Scale (spasticity)</measure>
    <time_frame>Study inclusion to end of intervention at 5 weeks</time_frame>
    <description>measure of the resistance of a muscle to passive stretch according to REsistance to PASsive movement protocol. From 0 to 4, 4 is high spasticity.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Stroke</condition>
  <arm_group>
    <arm_group_label>intervention group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>group focus on lower limb strength training with a seated robotic device</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>physiotherapy group as usual, not focused on strength training</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Group of strength training</intervention_name>
    <description>2x a week during 5 weeks, strengthening of weak muscles with the intensity recommended in the literature, i.e. 3-4x15 repetition at an intensity of 50 to 80% of the maximum force combined with serious games to stimulate patient involvement in strength training</description>
    <arm_group_label>intervention group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Group of physiotherapy not focus on strength training</intervention_name>
    <description>2x a week during 5 weeks, active physical therapy treatment based on movement</description>
    <arm_group_label>control group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Cerebral vascular accident of hemorrhagic or ischemic origin for more than 72 hours&#xD;
&#xD;
          -  Walking ability ≤ Functional Ambulatory Category level 4 (1-6)&#xD;
&#xD;
          -  Paresis of the lower limb: strength &lt;57/100 on the Motricity Index&#xD;
&#xD;
          -  Cognitive and memory functions allowing the patient to follow treatment instructions&#xD;
             and give informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Significant heart problem&#xD;
&#xD;
          -  Venous thrombosis less than 6 months&#xD;
&#xD;
          -  Musculoskeletal impairment not compatible with movement&#xD;
&#xD;
          -  Other neurological impairment&#xD;
&#xD;
          -  Oxygen-dependent&#xD;
&#xD;
          -  Blood pressure not stabilized&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Claude Pichonnaz, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Haute Ecole de Santé Vaud</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Claude Pichonnaz, PhD</last_name>
    <phone>+41 21 316 81 26</phone>
    <email>claude.pichonnaz@hesav.ch</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Nicolas Perret</last_name>
    <phone>+41 21 316 81 37</phone>
    <email>nicolas.perret@hesav.ch</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Institution de Lavigny</name>
      <address>
        <city>Lavigny</city>
        <state>Vaud</state>
        <zip>1175</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <contact>
      <last_name>Pierre-André Rapin, PhD</last_name>
      <email>pierre-andre.rapin@ilavigny.ch</email>
    </contact>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>August 12, 2021</study_first_submitted>
  <study_first_submitted_qc>August 18, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 25, 2021</study_first_posted>
  <last_update_submitted>August 18, 2021</last_update_submitted>
  <last_update_submitted_qc>August 18, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 25, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>lower limb</keyword>
  <keyword>robotic device</keyword>
  <keyword>strength training</keyword>
  <keyword>subacute</keyword>
  <keyword>rehabilitation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

